Latest Breaking News On - Dean wingerchuk - Page 1 : vimarsana.com

A new indirect comparison of three new FDA-approved treatment options for aquaporin4+ neuromyelitis optica has suggested that eculizumab is the most effective. But many limitations have been raised.

United statesMayo clinic in rochesterBrian weinshenkerDennis bourdetteBruce creeDepartment of neurologyOregon health science universityResearch in multiple sclerosisUniversity of california san franciscoEuropean committee for treatmentEuropean committeeMultiple sclerosisDean wingerchukMayo clinicMedscape medical newsCalifornia san francisco